Zura Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-58.52	-69.24	-32.39	6.85
Share-Based Compensation	9.7	9.66	0.33	0
Other Operating Activities	32.04	35.65	24.2	-7.95
Operating Cash Flow	-16.78	-15.05	-1.2	-1.1
Capital Expenditures	-0.01	0	0	0
Acquisitions	-13	-8	-12	0
Change in Investments	0	0	0	-139.38
Investing Cash Flow	-13.01	-8	-12	-139.38
Share Issuance / Repurchase	75.79	132.48	0	143.94
Debt Issued / Paid	0	-10	7.6	-0.12
Other Financing Activities	-0.15	-1.18	7.17	-2.61
Financing Cash Flow	75.64	121.29	14.77	141.21
Net Cash Flow	45.85	98.24	1.57	0.73
Free Cash Flow	-16.79	-15.05	-1.2	-1.1
Free Cash Flow Per Share	-0.36	-0.46	-5.27	-0.10

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).